Funded Research in Progress
The Sinclair Lab– Harvard University At the Sinclair Lab research is being conducted on the use of a unique DNA repair compound AC11 in combination with — NMN-NICOTINAMIDE MONO NUCLEOTIDE-. The unique combination of these two ingredients may create the basis of a oral compound to be used by NASA in future space flight journeys in order to buffer the damage to DNA caused by space radiation, and may also form the basis of a new oral AGE REVERSAL PRODUCT for the general public within the next year.
Wellomics Inc– University of New England Based at the University of New England Wellomics has created an AI program called “EPS” to help choose the key ingredients for new Neutraceutical Formulas which can target specific gene function and cellular pathways in order to improve aging and cellular function. Recently compared to “WATSON” the business software now in use to predict new business strategies, THE “EPS” CAN SEARCH 300,000 DATA BASES in a few hours to help choose the most recently discovered natural compounds that can be used for improving Healthspan and Cellular Aging.
The Elton John Foundation– Aids is a form of accelerated aging and the recent donation to the Elton John Foundation was given to help with research for improving the life quality of patents with Aids focusing on immune enhancement.
Feed a Billion– Childhood malnutrition creates changes in the Epigeneome of children that last a lifetime and decrease the quality of life as well as increase the incidence of disease. By helping to get appropriate nutrition early on to these children in need we can potentially decrease the incidence of disease as well as the cost for health care later on in life.
Da Vinci Biosciences Inc– Anaheim Calif. Funding to the lab at Da Vinci is focused on new cell therapies that can remove Senesecent Cells and limit the production of their products that have been shown to accelerate aging in healthy cell. The same therapy has been shown to enhance Immune Function tremendously in senior and or ill patients.. Another focus of the funding has been to explore new means of Epigenetic reprograming of damaged and aging cells in order to restore them to ideal function once again. This situation occurs after Chemo or Radio therapy.
Dana Farber Cancer Institute-Harvard University The research here is focused on using a unique strain of mice to document the changes in the epigenome in minute detail, so as to be able to evaluate the efficiency of different drugs as well as DNA segments to alter the gene activity of cells to function more optimally during the aging process–The first drug to be tested will be Metformin– which has already shown to be a very likely candidate for an anti aging drug in the near future.
Whitehead Institute– Funding for the Institute was given to encourage its ongoing work on natural plant compounds that can have an impact on improving cellular function in aging cells.
STEM CELL RESEARCH PLANNED FOR 2018
AT THE UNIVERSITY OF COSTA RICA, SAN JOSE, COSTA RICA.
AND IN CONJUNCTION WITH
THE REGENERATIVE MEDICINE INSTITUTE ,SAN JOSE, COSTA RICA.
“THE COMPARISON OF INTRAVENOUS AUTOLOGOUS AND ALLOGENIC MESENCHYMAL STEM CELLS FOR TREATING FRAILITY IN THE AGING POPULATION”
“THE USE OF AUTOLOGOUS MESENCHYMAL STEM CELLS FOR REGENERATIVE THERAPY OF OSTEOARTHRITS OF THE KNEES.”
“THE USE OF MODIFIED NK CELL THERAPY FOR IMMUNO ENHANCEMENT IN THE ELDERLY PATIENT”
“THE USE OF MODIFIED NK CELL THERAPY FOR THE REMOVAL OF SENESCENT CELLS AND TO CONTROL INTRINSIC INFLAMMATION.”
“THE USE OF ALLOGENIC MESENCHYMAL STEM CELLS FOR THE TREATMENT OF TRAUMATIC BRAIN DISORDERS”
“THE USE OF ALLOGENIC MESENCHYMAL STEM CELL FOR THE TREATMENT OF AUTISM”
“THE USE OF ALLOGENIC MESENCHYMAL STEM CELLS FOR THE TREATMENT OF AUTOIMMUNE DISEASE’S INCLUDING LYMES DISEASE”
“THE INTRAVENOUS USE OF A APHORESIS DERIVED STEM CELL COMPLEX FOR THE TREATMENT OF FRAILTY “